1. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression
- Author
-
Sheng-ming Xu, Chao-ji Shi, Rong-hui Xia, Li-zhen Wang, Zhen Tian, Wei-min Ye, Liu Liu, Shu-li Liu, Chun-ye Zhang, Yu-hua Hu, Rong Zhou, Yong Han, Yu Wang, Zhi-yuan Zhang, and Jiang Li
- Subjects
HPV ,OPSCC ,PD-L1 ,tumor immune microenvironment (TIM) ,genomic alterations ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Programmed death-ligand 1 (PD-L1) expression has been approved as an immune checkpoint inhibitor (ICI) response predictive biomarker; however, the clinicopathological and molecular features of HPV-positive oropharyngeal squamous cell carcinoma [HPV(+)OPSCC] based on PD-L1 expression are not well studied. We aimed to characterize clinicopathological, tumor immune microenvironmental, and molecular features of HPV(+)OPSCC with different PD-L1 expression scored by combined positive score (CPS). A total of 112 cases were collected from 2008-2021 and received PD-L1 and CD8 immunohistochemistry (IHC) staining. 71 samples received DNA sequencing out of which 32 samples received RNA sequencing for immune-related gene alterations or expression analysis. The 32 samples were also subjected to analysis of CD20, CD4, CD8, CD68, Foxp3 and P16 by multiplex immunofluorescence (mIF) staining, and the immune markers were evaluated in the tumor body (TB), tumor margin (TM) and normal stroma (NS) regions separately. Our results showed that of 112 HPV(+)OPSCC tumors, high(CPS≥20), intermediate(1≤CPS
- Published
- 2022
- Full Text
- View/download PDF